2-73385903-TGGAGGAGGAGGAGGAGGAGGAGGAGGA-TGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGA
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP3BP6_Very_Strong
The NM_001378454.1(ALMS1):c.54_74dupGGAGGAGGAGGAGGAGGAGGA(p.Glu19_Glu25dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E25E) has been classified as Likely benign.
Frequency
Consequence
NM_001378454.1 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALMS1 | NM_001378454.1 | c.54_74dupGGAGGAGGAGGAGGAGGAGGA | p.Glu19_Glu25dup | disruptive_inframe_insertion | Exon 1 of 23 | ENST00000613296.6 | NP_001365383.1 | |
| ALMS1 | NM_015120.4 | c.54_74dupGGAGGAGGAGGAGGAGGAGGA | p.Glu19_Glu25dup | disruptive_inframe_insertion | Exon 1 of 23 | NP_055935.4 | ||
| LOC105374804 | XR_007087045.1 | n.-243_-223dupTCCTCCTCCTCCTCCTCCTCC | upstream_gene_variant | |||||
| LOC105374804 | XR_007087053.1 | n.-243_-223dupTCCTCCTCCTCCTCCTCCTCC | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000836 AC: 12AN: 143532Hom.: 0 Cov.: 0 show subpopulations
GnomAD4 exome AF: 0.0000735 AC: 41AN: 557726Hom.: 0 Cov.: 0 AF XY: 0.0000638 AC XY: 19AN XY: 297820 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000835 AC: 12AN: 143636Hom.: 0 Cov.: 0 AF XY: 0.0000718 AC XY: 5AN XY: 69662 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Alstrom syndrome Uncertain:1
- -
not specified Benign:1
Variant summary: ALMS1 c.57_74dup18 (p.Glu23_Glu28dup) results in an in-frame duplication that is predicted to duplicate 6 amino acids into the ALMS repeat region/Glu repetitive region (Glu13_Glu28) of the encoded protein. The variant was absent in 83366 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.57_74dup18 in individuals affected with Alstrom Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Other duplication variants located in this Glu repetitive region (examples: c.54_74dup21/p.Glu22_Glu28dup, c.60_74dup15/p.Glu24_Glu28dup) have been classified as likely benign by our laboratory. Furthermore, there are no reports of other variants in this Glu repetitive region in the HGMD database. One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as benign. Based on the evidence outlined above, the variant was classified as as likely benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at